ATG5 and neoplasm: Furthermore, recent evidence revealed that six polymorphisms ATG2B rs3759601, ATG16L1 rs2241880, ATG10 rs1864183, NOD2 rs2066844 and rs2066845 and ATG5 rs2245214 were associated with a predisposition to tumor development, particularly in glioblastoma [167].